It very well may be difficult to explore the coronavirus pandemic, and it tends to be considerably harder in case you’re a malignancy persistent and experiencing medicines.
David West lives in West Columbia. On Nov. 20, 2014, he was determined to have stage 4 pancreatic neuroendocrine malignant growth.
“I’m still in treatment, and my tumors have not gone away. They continue to grow some, I have 18 different tumors. But I keep going,” said West.
He’s far outperformed that a half year, yet is presently getting his cancer treatments while living through a pandemic.
“You just have to be extra cautious and watch what you do. Stay isolated as much as possible,” said West.
Due to the pandemic, his PCPs chose to stop his every day chemotherapy pill. In any case, that wasn’t best for him.
“They were concerned that my immune system would be weakened, so they took me off the chemo. But then they figured out that since the tumor marker jumped up so high, that it was better since I do have cancer to fight the cancer than it is to worry about COVID-19 I guess,” said West.
He’s immunocompromised through his chemo and medicines. Along these lines and his age, he’s at high hazard for contracting COVID-19.
“Every time I go out somewhere, I wear a mask. A lot of people, I’d say 50% of people quit wearing masks now,” said West.
In the course of the most recent couple of months, the American Cancer Society Cancer Action Network conveyed two overviews to malignant growth patients and survivors to figure out how the pandemic affected them.
“Basically the results of the surveys showed many a lot of different health impacts and financial impacts that the COVID-19 pandemic is having on cancer patients and survivors,” said Taylor Hall, Media Advocacy Manager, American Cancer Society Cancer Action Network South Carolina.
“I think the longer the pandemic stretches out, the greater worry people have,” said West.
“Facing a cancer diagnosis is hard enough, and facing it amid a pandemic is a whole other kind of nightmare,” said Hall.